Non Heparin Anticoagulants for VTE Treatment

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 21
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2021-07-14T01:00:39-04:00",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2022-10-13T09:49:03.000-04:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Institutes for Research Steward",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for non-heparin anticoagulants for VTE treatment.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent non-heparin anticoagulants given for treatment of a VTE.),(Exclusion Criteria: Excludes concepts that represent anticoagulants given for VTE prophylaxis.\nExcludes concepts that represent heparin.)",
  "name" : "NonHeparinAnticoagulantsForVTETreatment",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1232082",
      "display" : "rivaroxaban 15 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1232086",
      "display" : "rivaroxaban 20 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1364445",
      "display" : "apixaban 5 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1549683",
      "display" : "{42 (rivaroxaban 15 MG Oral Tablet [Xarelto]) / 9 (rivaroxaban 20 MG Oral Tablet [Xarelto]) } Pack [Xarelto Kit]",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1992427",
      "display" : "{74 (apixaban 5 MG Oral Tablet) } Pack",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854238",
      "display" : "0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854241",
      "display" : "0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854245",
      "display" : "0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854248",
      "display" : "1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854252",
      "display" : "1 ML enoxaparin sodium 150 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "854255",
      "display" : "enoxaparin sodium 100 MG/ML Injectable Solution",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861356",
      "display" : "0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861363",
      "display" : "0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "861365",
      "display" : "0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978736",
      "display" : "0.3 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978740",
      "display" : "0.5 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978744",
      "display" : "0.6 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978746",
      "display" : "0.72 ML dalteparin sodium 25000 UNT/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978755",
      "display" : "1 ML dalteparin sodium 10000 UNT/ML Prefilled Syringe",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978759",
      "display" : "dalteparin sodium 10000 UNT/ML Injectable Solution",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "978777",
      "display" : "dalteparin sodium 25000 UNT/ML Injectable Solution",
      "version" : "06052023"
    } ],
    "offset" : 0,
    "total" : 21,
    "identifier" : "urn:uuid:ab02a627-8dc8-4ee4-8737-91fd6f32a6bd",
    "timestamp" : "2023-06-29T18:53:41-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Non Heparin Anticoagulants for VTE Treatment",
  "extension" : [ {
    "valueString" : "American Institutes for Research Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2021-07-14",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "769bd2b7-d57c-4d8d-9890-9c046acd93be",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.172",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1147.172"
  } ],
  "version" : "20210714"
}